(NYSE:DNA) BOSTON, Aug. 29, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today released the following notice: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION WEINING HU, derivatively on behalf of GINKGO BIOWORKS HOLDINGS, INC., a Delaware corporation, Plaintiff, vs....
Related Questions
How will the settlement affect Ginkgo Bioworks' financials and earnings outlook?
What does the resolution of these derivative lawsuits indicate about the company's governance and potential future litigation risk?
Could the settlement influence investor sentiment and the DNA stock's volatility in the short term?